Please login to the form below

Not currently logged in
Email:
Password:

Nancy Simonian joins board of Seattle Genetics

Former chief medical officer at Takeda subsidiary Millennium brings both clinical and regulatory experience

Nancy Simonian, former chief medical officer at Takeda subsidiary Millennium, has been appointed to the board of US biotech Seattle Genetics.

She spent ten years at Millennium from 2001 to 2011, leading clinical and regulatory activities, working on such product approvals as Velcade.

For the past year, she has worked as an independent consultant to the biotech industry.

“Nancy brings significant experience in all aspects of clinical development, regulatory affairs and medical research, as well as program management and strategic prioritization of product portfolios,” said Dr Clay Siegall, president and CEO of Seattle Genetics.

“She is a valuable addition to our Board as we continue executing on our broad clinical development program for Adcetris and advancing our pipeline of clinical and preclinical products aimed at improving treatments for people with cancer.”

Prior to her time at Millennium, Simonian was VP of clinical research at Biogen, as well as assistant professor of neurology at Massachusetts General Hospital and Harvard Medical School.

She said of her appointment: “I look forward to working with the Board and the management team to maximise the potential of Seattle Genetics' antibody-drug conjugate technology, collaborations and value to patients.”

27th March 2012

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...
wearable health tech
A cultural shift in clinical research
Research organisations across the board are experimenting with new technologies...

Infographics